This is a working overview of LC-MS/MS, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-05-24. Anything still debated is marked as such rather than presented as settled.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C or lower | Desiccated and protected from light |
| Common analytical method | LC-MS/MS | Detects parent drug and metabolites |
| Solubility class | Lipophilic; soluble in organic solvents | Low aqueous solubility |
| Molecular weight | 437.94 g/mol | Calculated from reported formula |
| Synonyms | SR9009; REV-ERB agonist | Code name used in scientific literature |
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
=== No development reported === 4-Chlorokynurenine (4-CL-KYN; 7-CL-KYNA; AV-101) – ionotropic glutamate NMDA receptor antagonist and 3-hydroxyanthranilate oxidase inhibitor [146] α-Synuclein picobody (a-syn-pico) – positron-emission tomography (PET) enhancer – diagnosis [147] A-86929 – dopamine D1 receptor agonist [148] AB-4166 – microbiome modulator [149] ACI-12589 – positron-emission tomography (PET) enhancer – diagnosis [150] Affitope-PD03 (PD03; PD03A) – α-synuclein inhibitor and immunostimulant [151] ANPD-002 (ANPD002) – dopaminergic cell replacement [152] AP-472 – metabotropic glutamate mGlu4 receptor positive allosteric modulator [153] Aplindore (DAB-452; palindore; SLS-006; WAY-DAB 452) – dopamine D2 receptor agonist [154] Armesocarb (MLR-1019) – atypical dopamine reuptake inhibitor (DRI) [155] Atuzaginstat (COR-388) – peptide hydrolase inhibitor [156] ATV:aSyn (ATV:α-synuclein; ATV:αSyn) – α-synuclein inhibitor [157] Autologous adipose derived mesenchymal stem cells - Hope Biosciences – cell replacement [158] AZ-001 – undefined mechanism of action [159] Beperminogene perplasmid (AMG-0001; Collategene; hepatocyte growth factor gene therapy) – gene transference and hepatocyte growth factor (HGF) expression stimulant [160] BTRX-246040 (LY-2940094) – nociceptin receptor (NOP) antagonist [161] Cannabidiol/tetrahydrocannabinol (CBD/THC; CanChew; MedChew; THC/CBD) – cannabinoid CB1 and CB2 receptor agonist and other actions [162] Carbidopa/levodopa (WD-1603) – combination of carbidopa (aromatic L-amino acid decarboxylase (AAAD) inhibitor) and levodopa (dopamine precursor) [163] Carbidopa/levodopa oral solution (EXN-32) – combination of carbidopa (aromatic L-amino acid decarboxylase (AAAD) inhibitor) and levodopa (dopamine precursor) [164] Ciforadenant (CPI-444, V-81444) – adenosine A2A receptor antagonist CM-4612 (CM-ADHD; CM-AT; CM-PK) – enzyme replacement and modulator [165] Crisdesalazine (AAD-2004) – microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor [166] CTx-GBA1 – gene transference [167] Cu(II)ATSM (copper(II)-ATSM; Cu-ATSM) – neuron modulator [168] Debamestrocel (autologous bone marrow derived mesenchymal stem cell therapy; NurOwn) – dopaminergic cell replacement [169] DNL-201 – leucine-rich repeat kinase 2 (LRRK2) inhibitor [170] Dopamine intranasal – non-selective dopamine receptor agonist [171] DX-0308 (DX-308) – retinoic acid metabolism modulator [172] Emrusolmin (anle-138b; TEV-56286) – α-synuclein inhibitor and protein aggregation inhibitor [173] ESB-1609 – sphingosine-1-phosphate (S1P) receptor agonist [174] ESB-5070 – leucine-rich repeat kinase 2 (LRRK2) inhibitor [175] F-14413 – α2-adrenergic receptor inverse agonist [176] FB-101 (1ST-102) – Bcr-Abl tyrosine kinase inhibitor [177] Fibroblast growth factor 1 (FGF-1) – fibroblast growth factor stimulant and angiogenesis-inducing agent [178] GO-101 – gene transference [179] GT-02329 – β-glucocerebrosidase (GCase) activator and/or chaperone [180] ISC-hpNSC (human parthenogenetic neural stem cells) – dopaminergic cell replacement [181] Itanapraced (CHF-5074; CSP-1103) – γ-secretase modulator and non-steroidal anti-inflammatory drug (NSAID) derivative lacking cyclooxygenase (COX) inhibition [182] Levodopa deuterated (deuterium-containing levodopa; SD-1077) – dopamine precursor and indirect non-selective dopamine receptor agonist [183] Liatermin (BVF-014; GDNF; glial-derived neutrotrophic factor; r-metHuGDNF) – neuron stimulant [184] Lu-AE-04621 (Lu-AE04621) – dopamine receptor agonist (prodrug of Lu-AA40326) [185] Masupirdine (SUVN-502; SUVN502) – serotonin 5-HT6 receptor antagonist [186] Mesocarb (MLR-1017) – atypical dopamine reuptake inhibitor (DRI) [187] MTK-458 – protein-serine-threonine kinase stimulant [188] NPT-200-11 (NPT200-11; UCB-1332) – α-synuclein inhibitor [189] NPT-520-34 (NPT520-34) – 1-phosphatidylinositol 3 kinase modulator and other actions [190] ODM-104 – catechol O-methyltransferase (COMT) inhibitor [191] OP-101 (dendrimer N-acetylcysteine) – various actions [192] OP-501 – catechol O-methyltransferase (COMT) inhibitor [193] Ordopidine (ACR-325) – low-affinity dopamine D2 receptor antagonist and dopaminergic stabilizer [194] PD-04 (a-Syn-PD-04; Affitope PD-04; PD04) – peptide vaccine against α-synuclein [195] Rasagiline – monoamine oxidase B (MAO-B) inhibitor [196] Rasagiline transdermal patch (TPU-002RA) – monoamine oxidase B (MAO-B) inhibitor [197] Research programme: adenosine A2A/A1 selective antagonists - Domain Therapeutics/CleveXel Pharma (CVXL-0069; DT-1133; DT0926; FP-0692; FP-1133) – adenosine A1 receptor antagonists and adenosine A2A receptor antagonists [198] Research programme: catalytic antioxidants - Aeolus Pharmaceuticals (AEOL-10113; AEOL-11207) – antioxidants [199] Research programme: central nervous system therapeutics - Delpor – undefined mechanism of action [200] Research programme: cGAS/STING antagonists - IFM Due – nucleotidyltransferase inhibitors [201] Research programme: COMT inhibitors - Avalo Therapeutics (AVTX-406; CERC-425; CERC-406) – catechol O-methyltransferase (COMT) inhibitors [202] Research programme: dopamine D1 receptor agonists - Takeda – dopamine D1 receptor agonists [203] Research programme: exosome therapeutics - ArunA Biomedical – undefined mechanism of action [204] Research programme: GPCR modulators - Nxera Pharma – various actions [205] Research programme: KEAP1 inhibitors - Keapstone Therapeutics – Kelch-like ECH-associated protein 1 (KEAP1) inhibitors [206] Research programme: long-acting neuropsychiatric therapeutics - Teva (NP-201; NP-202; risperidone/ropinirole implants) – various actions [207] Research programme: LRRK2 inhibitor - GlaxoSmithKline – leucine-rich repeat kinase 2 (LRRK2) inhibitors [208] Research programme: LRRK2 inhibitors - Novartis – leucine-rich repeat kinase 2 (LRRK2) inhibitors [209] Research programme: neurodegenerative disorder gene therapies - Denali Therapeutics (AAV-LF2; CNS-directed AAV-based gene therapies) – gene transference [210] Research programme: neurodegenerative disorders therapeutics - BioArctic Neuroscience (AD-0802; AD-1502; AD-2203; AE-1501; BAN-2203; BAN-2502; BAN2401 back-up) – various actions [211] Research programme: neurodegenerative disorder therapeutics - Celgene Corporation/Evotec (BMSxxx) – cell replacements [212] Research programme: neurodegenerative disease therapeutics - ProteoTech (DP-68; DP-74; PD-61-W3; PeptiClere; PTI-19; PTI-51; PTI-51-CH3; Synuclere; TauPro) – various actions [213] Research programme: neurological disorders therapeutics - Gloriana therapeutics (ECB-PD; ECT-PD; Meteorin; Ns-G34; NsG-0301; NsG-33) – glial cell line-derived neurotrophic factor modulators [214] Research programme: Parkinson's disease therapeutics - Alectos Therapeutics – glucocerebrosidase 2 (GBA2) protein inhibitor [215] Research programme: Parkinson's disease therapies - Zymes (co-Q10; coenzyme Q10; ubidecarenone) – antioxidants [216] Research programme: Parkinson's disease therapy - AbbVie – dopamine D2 and D3 receptor agonists [217] Research programme: positive allosteric modulators - Proximagen – various actions [218] Research programme: protective autoimmunity enhancer - Proneuron Biotechnologies (PN-277) – immunomodulators [219] Research programme: protein phosphatase 2A modulators - Signum Biosciences (SIG-1012; SIG-1106) – protein phosphatase 2A (PP2A) modulator [220] Research programme: small molecule therapeutics - Amathus Therapeutics – mitochondrial protein stimulants [221] Research programme: small molecule therapeutics - Aranda Pharma/Tarrex Biopharma (ADA-308; ADA-409; Backup; MDA-308; MDA-409) – androgen receptor antagonists [222] Research programme: transmembrane protein 175 agonists - AbbVie/Caraway Therapeutics – TMEM175 stimulants [223] Rotigotine controlled release (SER-214) – non-selective dopamine receptor agonist and other actions [224] S-32504 – dopamine D2 and D3 receptor agonist [225] SAGE-324 (BIIB-124) – GABAA receptor positive allosteric modulator and neurosteroid [226] Saracatinib (AZD-0530) – Src-family kinase inhibitor [227] Selegiline transdermal (Emsam) – monoamine oxidase B (MAO-B) inhibitor and other actions [228] Seridopidine (ACR343; ACR-343) – dopamine receptor modulator and so-called "dopaminergic stabilizer" [229] SLS-004 (LV-dCas9-DNMT3A) – gene therapy and α-synuclein expression inhibitor [230] Sonlicromanol (KH-176) – prostaglandin-E synthase inhibitor and reactive oxygen species modulator [231] SPN-803 (SPN803) – undefined mechanism of action [232] STEL-101 (AMA-101; STL-101) – undefined mechanism of action [233] UB-312 – immunostimulant [234] YKP-10461 (SKL-PD; YKP10461) – monoamine oxidase B (MAO-B) inhibitor [235] YTX-7739 – stearoyl-CoA desaturase inhibitor [236] Xenon (NBTX-001) – ionotropic glutamate NMDA receptor antagonist [237]
=== Hydrolysis === DBNPA undergoes rapid pH-dependent hydrolysis in aqueous environments, leading to the formation of different degradation products. The C-Br bonds break down rapidly into smaller organic and inorganic byproducts when exposed to neutral to alkaline environments due to nucleophilic substitution. DBNPA can endure longer in acidic settings since the hydrolysis rate is lower. The pH has a significant impact on DBNPA's breakdown. The main degradation product at pH 5 is dibromoacetic acid (DBAA), which makes up 30.6% of all DBNPA breakdown products. The breakdown mechanism changes as the pH rises, favouring the synthesis of dibromoacetonitrile (DBAN), which dominates at pH 7 (54.5%) and pH 9 (38.6%). Ammonia, carbon dioxide, bromide ions, and cyanoacetic acid are produced by further hydrolysis in neutral or slightly alkaline conditions.
=== Initial stranding === The carcass was first spotted on the evening of November 30, 1896, by two young boys, Herbert Coles and Dunham Coretter, while bicycling along Anastasia Island. The enormous mass was half buried in the sand, having sunk under its immense weight. The two boys thought the carcass was the remains of a beached whale, as a similar stranding had occurred two years earlier near the mouth of the Matanzas River, located several miles to the south of St. Augustine (see map). The two boys returned to St. Augustine the same day and reported their discovery to a local physician, Dr. DeWitt Webb. Webb, who was the founder of the St. Augustine Historical Society and Institute of Science, came to the beach the following day, December 1, to examine the remains. He would be the only known person of an academic background to see the specimen in situ. His first impression was that it was the remains of an animal, very mutilated, and in an advanced state of decomposition. The carcass was very pale pink, almost white, in colour, with a silver reflection in the sunlight. It was composed of a rubbery substance of a very hard consistency, such that it could only be cut with great difficulty. The part of the carcass that was visible measured 18 feet (approx. 6 meters) in length and 7 feet (approx. 2+1⁄2 meters) in width. Webb estimated its weight at nearly 5 tons, if not more. He believed it was the remains of a giant octopus, as it appeared to have the stumps of four arms, with another arm buried nearby.
== Pumps used in high-pressure chromatography == Pumps used in high-pressure chromatography such as HPLC and ion chromatography are much like small piston metering pumps. For wear resistance and chemical resistance to solvents, etc., typically the pistons are made of artificial sapphire and the ball check valves have ruby balls and sapphire seats. To produce good chromatograms, it is desirable to have a pumping flow rate as constant as possible. Either a single piston pump with a quick refill is used or a double pump head with coordinated piston strokes is used to provide as constant a pumping rate as possible.
Biosynthesis of a particular hormone in a particular tissue. Storage and secretion of the hormone. Transport of the hormone to the target cell(s). Recognition of the hormone by an associated cell membrane or intracellular receptor protein. Relay and amplification of the received hormonal signal via a signal transduction process: This then leads to a cellular response. The reaction of the target cells may then be recognized by the original hormone-producing cells, leading to a downregulation in hormone production. This is an example of a homeostatic negative feedback loop. Breakdown of the hormone. Exocytosis and other methods of membrane transport are used to secrete hormones when the endocrine glands are signaled. The hierarchical model is an oversimplification of the hormonal signaling process. Cellular recipients of a particular hormonal signal may be one of several cell types that reside within a number of different tissues, as is the case for insulin, which triggers a diverse range of systemic physiological effects. Different tissue types may also respond differently to the same hormonal signal.
Sources: en.wikipedia.org
In particular, decreased access to public health services such as syringe exchange programs and confiscation of syringes can precipitate a cascade of health harms. Geographic diffusion of epidemics from the northern border states elsewhere is also possible with the rotation of police and military personnel stationed in drug conflict areas with high infection prevalence. With increased drug use, there has been a parallel rise in demand for drug user treatment in Mexico.
In optical interferometry, the pathlength difference between sample and reference arms can be measured by ToF methods, such as frequency modulation followed by phase shift measurement or cross correlation of signals. Such methods are used in laser radar and laser tracker systems for medium-long range distance measurement. In neutron time-of-flight scattering, a pulsed monochromatic neutron beam is scattered by a sample. The energy spectrum of the scattered neutrons is measured via time of flight. In kinematics, ToF is the duration in which a projectile is traveling through the air. Given the initial velocity
...domestic crisis within the Soviet system. ... It may be that the thermodynamic law of entropy has ... caught up with the Soviet system, which now seems to expend more energy on simply maintaining its equilibrium than on improving itself. We could be seeing a period of foreign movement at a time of internal decay.
Brettanomyces (Teleomorph Dekkera) Candida (Teleomorphs for different species from several genera including Pichia, Metschnikowia, Issatchenkia, Torulaspora and Kluyveromyces) Kloeckera (Teleomorph Hanseniaspora), usually the most common "wild yeast" found in the vineyard. Some species are known as "killer yeast" that produce inhibitory levels of ethyl acetate and acetic acid that can kill off sensitive strains of Saccharomyces cerevisiae Saccharomycodes Schizosaccharomyces, the only wine yeast that reproduced by fission whereas most wine yeast reproduce by budding. Zygosaccharomyces, very alcohol-tolerant and can grow in wines up to 18% v/v. Additionally this yeast can survive in extremely high sugar levels (as much as 60% w/w or 60 Brix) and is very resistant to sulfur dioxide. Aureobasidium, particularly the "black yeast" species of Aureobasidium pullulans found in moist cellars that can contaminate aging wine in barrels.
Sources: en.wikipedia.org
transfer RNA (tRNA) Formerly referred to as soluble RNA (sRNA). A special class of RNA molecule, typically 76 to 90 nucleotides in length, that serves as a physical adapter allowing mRNA transcripts to be translated into sequences of amino acids during protein synthesis. Each tRNA contains a specific anticodon triplet corresponding to an amino acid that is covalently attached to the tRNA's opposite end; as translation proceeds, tRNAs are recruited to the ribosome, where each mRNA codon is paired with a tRNA containing the complementary anticodon. Depending on the organism, cells may employ as many as 41 distinct tRNAs with unique anticodons; because of codon degeneracy within the genetic code, several tRNAs containing different anticodons carry the same amino acid.
"There's no way Rush will ever exist again because Neil's not here to be a part of it... that's not to say that we can't do other things and we can't do things that benefit our communities and all of that. I have lots of plans for that sort of thing that don't necessarily include Geddy. I get asked this all the time—are we gonna do this, or are we gonna do that? Who knows? All I know is we still love each other and we're still very, very good friends, and we always will be."
=== Into Germany === After helping to secure the Ruhr, the 82nd Airborne Division took over Ludwigslust past the Elbe River, accepting the surrender of over 150,000 men of Lieutenant General Kurt von Tippelskirch's 21st Army on 2 May 1945. General Omar Bradley, commanding the US 12th Army Group, stated in a 1975 interview with Gavin that Field Marshal Sir Bernard Montgomery, commanding the Anglo-Canadian 21st Army Group, had told him that German opposition was too great to cross the Elbe. When Gavin's 82nd crossed the river, in company with the British 6th Airborne Division, the 82nd Airborne Division moved 36 miles in one day and captured over 100,000 troops, causing great laughter in Bradley's 12th Army Group headquarters.
Sources: en.wikipedia.org
Liquid chromatography-tandem mass spectrometry is a common approach. It can detect the parent compound and its metabolites in biological matrices.
Research samples are typically kept frozen, desiccated, and protected from light. Stock solutions are often aliquoted to reduce freeze-thaw cycles.
High-performance liquid chromatography and nuclear magnetic resonance are standard for purity and identity. Mass spectrometry confirms molecular weight.
Research-grade SR9009 is typically stored frozen at about minus twenty degrees Celsius, protected from light and moisture. Stock solutions are often kept in aliquots to avoid repeated freeze-thaw cycles. Specific storage conditions should follow the supplier's documentation.